Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon

Journal of Virology

Volumn 79, Issue 12, 2005, Pages 7768-7776

  Obojes, Karola ^a   Andres, Oliver ^a   Kim, Kwang Sik ^b   Däubener, Walter ^c   Schneider Schaulies, Jürgen ^a,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRYPTOPHAN;

ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; ARTICLE; ASTROCYTE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; ENZYME INDUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOID CELL; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS;

MEASLES VIRUS; RODENTIA;

EID: 19944397134     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.12.7768-7776.2005     Document Type: Article

References (63)

1. Adams, L. B., J. B. Hibbs, R. R. Taintor, and J. L. Krahenbuhl. 1990. Microstatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725-2729.
2. Adams, O., K. Besken, C. Oberdörfer, C. R. MacKenzie, D. Rössing, and W. Däubener. 2004. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect. 6:806-812.
3. Adams, O., K. Besken, C. Oberdörfer, C. R. MacKenzie, O. Takikawa, and W. Däubener. 2004. Role of indoleamine 2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 78:2632-2636.
4. Agresti, C., D. D'Urso, and G. Levi. 1996. Reversible inhibitory effects of interferon-gamma and tumor necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation. Eur. J. Neurosci. 8:1106-1116.
5. Andres, O., K. Obojes, K. S. Kim, V. ter Meulen, and J. Schneider-Schaulies. 2003. CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J. Gen. Virol. 84:1189-1197.
6. Binder, G. K., and D. E. Griffin. 2001. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293:303-306.
7. Bodaghi, B., O. Goueau, D. Zipeto, L. Laurent, J.-L. Virelizier, and S. Michelson. 1999. Role of IFN-gamma-induced indolamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162:957-964.
8. Brown, R. R., Y. Ozaki, S. P. Datta, E. C. Borden, P. M. Sondel, and D. G. Malone. 1991. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv. Exp. Med. Biol. 294:425-435.
9. Burudi, E. M. E., C. G. Marcondes, D. D. Watry, M. Zandonatti, M. A. Taffe, and H. S. Fox. 2002. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J. Virol. 76: 12233-12241.
10. Cantin, E., B. Tanamachi, and H. Openshaw. 1999. Role for gamma interferon in control of herpes simplex virus type I reactivation. J. Virol. 73: 3418-3423.
11. Chesler, D. A., and C. S. Reiss. 2002. The role of IFN-gamma in immune response to viral infections of the central nervous system. Cytokine Growth Factor Rev. 13:441-454.
12. Choudhary, S., J. Gao, D. W. Leaman, and B. P. De. 2001. Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription. J. Virol. 75:4823-4831.
13. Corbin, J. G., D. Kelly, E. M. Rath, K. D. Baerwald, K. Suzuki, and B. Popko. 1996. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebral development. Mol. Cell. Neurosci. 7:354-370.
14. Däubener, W., C. Remscheid, S. Nockmann, K. Pilz, S. Seghrouchni, C. MacKenzie, and U. Hadding. 1996. Antiparasitic effector mechanism in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha. Eur. J. Immunol. 26:487-492.
15. Däubener, W., N. Wanagat, K. Pilz, S. Seghrouchni, H. G. Fischer, and U. Hadding. 1994. A new, simple, bioassay for human IFN-gamma. J. Immunol. Methods 168:39-47.
16. Duprex, W. P., S. McQuaid, L. Hangartner, M. A. Billeter, and B. K. Rima. 1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J. Virol. 73: 9568-9575.
17. Eneroth, A., T. Andersson, T. Olsson, C. Orvell, E. Norrby, and K. Kristensson. 1992. Interferon-gamma-like immunoreactivity in sensory neurons may influence the replication of Sendai and mumps viruses. J. Neurosci. Res. 31:487-493.
18. Eneroth, A., K. Kristensson, A. Ljungdahl, and T. Olsson. 1991. Interferon-gamma-like immunoreactivity in developing rat spinal ganglia neurons in vivo and in vitro. J. Neurocytol. 20:225-231.
19. Finke, D., U. G. Brinckmann, V. ter Meulen, and U. G. Liebert. 1995. Gamma interferon is a major mediator of the antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469-5474.
20. Frese, M., V. Schwarze, K. Barth, N. Kriegr, V. Lohmann, S. Mihm, O. Haller, and R. Bartenschlager. 2002. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694-703.
21. Frumento, G., R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G. B. Ferrara. 2002. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196:459-468.
22. Fujigaki, S., K. Saito, K. Sekikawa, S. Tone, O. Takikawa, H. Fuji, H. Wada, A. Noma, and M. Seishima. 2001. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur. J. Immunol. 31:2313-2318.
23. Grant, R. S., H. Naif, S. J. Thuruthyil, N. Nasr, T. Littlejohn, O. Takikawa, and V. Kapoor. 2000. Induction of indoleamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent. J. Virol. 74:4110-4115.
24. Guillemin, G. J., G. Smythe, O. Takikawa, and B. J. Brew. 2005. Expression of indolamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49:15-23.
25. Gupta, S. L., J. M. Carlin, P. Pyati, W. Dai, E. R. Pfefferkorn, and M. J. Murphy, Jr. 1994. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62: 2277-2284.
26. Habara-Ohkubo, A., T. Shirahata, O. Takikawa, and R. Yoshida. 1993. Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase. Infect. Immun. 61:1810-1813.
27. Hara, T., S. Yamashita, H. Aiba, K. Nihei, N. Koide, R. A. Good, and K. Takeshita. 2000. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J. Neurovirol. 6:121-126.
28. Heyes, M. P., C. Y. Chen, E. O. Major, and K. Saito. 1997. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem. J. 326:351-356.
29. Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101-108.
30. Kündig, T. M., H. Hengartner, and R. M. Zinkernagel. 1993. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150:2316-2321.
31. MacKenzie, C. R., R. Langen, O. Takikawa, and W. Däubener. 1999. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma induced bacteriostasis but does not abrogate toxoplasmostasis. Eur. J. Immunol. 29:3254-3261.
32. Maloney, E. M., M. O. St. Clair, B. Widner, E. R. Werner, and D. Fuchs. 2000. Central nervous system activation of the indoleamine 2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J. Infect. Dis. 181:2037-2040.
33. Marin, V., G. Kaplanski, S. Grès, C. Farnarier, and P. Bongrand. 2001. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods 254:183-190.
34. Mellor, A. L., J. Sivakumar, P. Chandler, K. Smith, H. Molina, D. Moao, and D. H. Munn. 2001. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2: 64-68.
35. Moffett, J. R., and M. A. Namboodiri. 2003. Tryptophan and the immune response. Immunol. Cell Biol. 81:247-265.
36. Munn, D. H., and A. L. Mellor. 2004. IDO and tolerance to tumors. Trends Mol. Med. 1:15-18.
37. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1363-1372.
38. Nagano, I., S. Nakamura, M. Yoshioka, J. Onodera, K. Kogure, and Y. Itoyama. 1994. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 44:710-715.
39. Naniche, D., A. Yeh, D. Eto, M. Manchester, R. M. Friedman, and M. B. A. Oldstone. 2000. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J. Virol. 74:7478-7484.
40. Neumann, H., H. Schmidt, E. Wilharm, L. Behrens, and H. Wekerle. 1997. Interferon-gamma gene expression in sensory neurons: evidence for autocrine gene regulation. J. Exp. Med. 186:2023-2031.
41. Okada, H., T. Sato, A. Katayama, K. Higuchi, K. Shichijo, T. Tsuchiya, N. Takayama, Y. Takeuchi, T. Abe, N. Okabe, and M. Tashiro. 2001. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Arch. Virol. 146:859-874.
42. Ono, N., H. Tatsuo, Y. Hidaka, T. Aoki, H. Minagawa, and Y. Yanagi. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75:4399-4401.
43. Ovsyannikova, I., K. Reid, R. Jacobson, A. Oberg, G. Klee, and G. Poland. 2003. Cytokine production patterns and antibody response to measles vaccine. Vaccine 21:3946-3953.
44. Palosaari, H., J.-P. Parisien, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77:7635-7644.
45. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641-1647.
46. Patterson, C. E., D. M. P. Lawrence, L. A. Echols, and G. F. Rall. 2002. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 76: 4497-4506.
47. Patterson, J. B., D. Thomas, H. Lewicki, M. A. Billeter, and M. B. Oldstone. 2000. V and C proteins of measles virus function as virulence factors in vivo. Virology 267:80-89.
48. Sainz, R., and W. P. Halford. 2002. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76:11541-11550.
49. Sardar, A. M., and G. P. Reynolds. 1995. Frontal cortex indolamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia. Neurosci. Lett. 187:9-12.
50. Schneider-Schaulies, J., F. Kirchhoff, J. Archelos, and M. Schachner. 1991. Down-regulation of myelin-associated glycoprotein on Schwann cells by interferon-gamma and tumor necrosis factor-alpha affects neurite outgrowth. Neuron 7:995-1005.
51. Schneider-Schaulies, J., V. ter Meulen, and S. Schneider-Schaulies. 2003. Measles infection of the central nervous system. J. Neurovirol. 9:247-252.
52. Schneider-Schaulies, S., J. Schneider-Schaulies, A. Schuster, M. Bayer, J. Pavlovic, and V. ter Meulen. 1994. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 68:6910-6917.
53. Schnorr, J. J., S. Schneider-Schaulies, A. Simon-Jodicke, J. Pavlovic, M. A. Horisberger, and V. ter Meulen. 1993. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67:4760-4768.
54. Shaffer, J. A., W. J. Bellini, and P. A. Rota. 2003. The C protein of measles virus inhibits type I interferon response. Virology 315:389-397.
55. Stins, F. M., F. Gilles, and K. S. Kim. 1997. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76:81-90.
56. Takeuchi, K., S. Kadota, M. Takeda, N. Miyajima, and K. Nagata. 2003. Measles virus V protein blocks interferon (IFN)-α/β but not IFN-γ signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 545:177-182.
57. Takikawa, O., T. Kuroiwa, F. Yamazaki, and R. Kido. 1988. Mechanism of interferon-gamma action: characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263:2041-2048.
58. ter Meulen, V., J. R. Stephenson, and H. W. Kreth. 1983. Subacute sclerosing panencephalitis, p. 105-159. In H. Fraenkel-Conrat and R. R. Wagner (ed.), Comprehensive virology, vol. 18. Plenum Press, New York, N.Y.
59. Terness, P., T. M. Bauer, L. Röse, C. Dufter, A. Watzlik, H. Simaon, and G. Opelz. 2002. Inhibition of allogenic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196:447-457.
60. Uyttenhove, C., L. Pilotte, I. Théate, V. Stroobant, D. Colau, N. Parmentier, T. Boon, and B. J. Van den Eynde. 2003. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9:1269-1274.
61. Weidinger, G., G. Henning, V. ter Meulen, and S. Niewiesk. 2001. Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown of resistance against measles-induced encephalitis in mice. J. Virol. 75:3059-3065.
62. Wirleitner, B., G. Neurauter, K. Schrocksnadel, B. Frick, and D. Fuchs. 2003. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 10:1581-1591.
63. Yokota, S.-I., H. Saito, T. Kubota, N. Yokosawa, K.-I. Amano, and N. Fujii. 2003. Measles virus suppresses interferon-α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-α receptor complex. Virology 306:135-146.